{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:17:56Z","timestamp":1790021876084,"version":"4.0.1"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019706","name":"Qatar Biomedical Research Institute, Hamad Bin Khalifa University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019706","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.nbd.2023.105997","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T20:35:23Z","timestamp":1673296523000},"page":"105997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Cross-sectional proteomic expression in Parkinson's disease-related proteins in drug-na\u00efve patients vs healthy controls with longitudinal clinical follow-up"],"prefix":"10.1016","volume":"177","author":[{"given":"Ilham Yahya","family":"Abdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bartl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Dakna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houari","family":"Abdesselem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour","family":"Majbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Trenkwalder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"El-Agnaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brit","family":"Mollenhauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2023.105997_bib404","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1743-8454-7-6","article-title":"Microarray-based gene expression profiling and DNA copy number variation analysis of temporal fossa arachnoid cysts","volume":"7","author":"Aarhus","year":"2010","journal-title":"Cerebrospinal Fluid Res."},{"issue":"5","key":"10.1016\/j.nbd.2023.105997_bb0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrn3024","article-title":"Not(ch) just development: notch signalling in the adult brain","volume":"12","author":"Ables","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.nbd.2023.105997_bb0010","article-title":"Cubo E. Can plasma \u03b1-synuclein help us to differentiate parkinson\u2019s disease from essential tremor?","volume":"11","author":"Albillos","year":"2021","journal-title":"Tremor Other Hyperkinetic Move. [Internet]."},{"issue":"1","key":"10.1016\/j.nbd.2023.105997_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-020-01130-8","article-title":"CD36 deficiency affects depressive-like behaviors possibly by modifying gut microbiota and the inflammasome pathway in mice","volume":"11","author":"Bai","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.nbd.2023.105997_bb0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000112832","article-title":"Red blood cells are the major source of alpha-synuclein in blood","volume":"5","author":"Barbour","year":"2008","journal-title":"Neurodegener. Dis. [Internet]."},{"issue":"10","key":"10.1016\/j.nbd.2023.105997_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19102973","article-title":"Role of mitogen activated protein kinase signaling in Parkinson\u2019s disease","volume":"19","author":"Bohush","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl. 2","key":"10.1016\/j.nbd.2023.105997_bb0030","doi-asserted-by":"crossref","first-page":"S281","DOI":"10.3233\/JPD-191721","article-title":"Brain-first versus gut-first Parkinson\u2019s disease: a hypothesis","volume":"9","author":"Borghammer","year":"2019","journal-title":"J. Parkinsons Dis."},{"issue":"20","key":"10.1016\/j.nbd.2023.105997_bb0035","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/01.wnl.0000312279.49272.9f","article-title":"Invited article: nervous system pathology in sporadic Parkinson disease","volume":"70","author":"Braak","year":"2008","journal-title":"Neurology."},{"issue":"1700","key":"10.1016\/j.nbd.2023.105997_bb0040","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2015.0429","article-title":"Impairments of neural circuit function in Alzheimer\u2019s disease","volume":"371","author":"Busche","year":"2016","journal-title":"Philos. Trans. Royal Soc. B: Biol. Sci."},{"issue":"34","key":"10.1016\/j.nbd.2023.105997_bb0045","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1523\/JNEUROSCI.0278-19.2019","article-title":"Axonal growth of midbrain dopamine neurons is modulated by the cell adhesion molecule ALCAM through trans-heterophilic interaction with L1Cam, ChL1 and Semaphorin","volume":"39","author":"Bye","year":"2019","journal-title":"J. Neurosci."},{"issue":"FEB","key":"10.1016\/j.nbd.2023.105997_bb0050","article-title":"Inflammation, infectious triggers, and Parkinson\u2019s disease","volume":"10","author":"Caggiu","year":"2019","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2023.105997_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-14755-5","article-title":"Assessment of variability in the SOMAscan assay","volume":"7","author":"Candia","year":"2017","journal-title":"Sci. Rep."},{"issue":"7628","key":"10.1016\/j.nbd.2023.105997_bb0060","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature20412","article-title":"The road to restoring neural circuits for the treatment of Alzheimer\u2019s disease","volume":"539","author":"Canter","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2023.105997_bb0065","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3389\/fneur.2019.01388","article-title":"Plasma and serum alpha-synuclein as a biomarker of diagnosis in patients with Parkinson\u2019s disease","volume":"10","author":"Chang","year":"2020","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.nbd.2023.105997_bb0070","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4103\/1673-5374.244776","article-title":"Contactins in the central nervous system: role in health and disease","volume":"14","author":"Chatterjee","year":"2019","journal-title":"Neural Regen. Res."},{"issue":"8","key":"10.1016\/j.nbd.2023.105997_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biom10081177","article-title":"Contactin-1 is reduced in cerebrospinal fluid of Parkinson\u2019s disease patients and is present within Lewy bodies","volume":"10","author":"Chatterjee","year":"2020","journal-title":"Biomolecules."},{"issue":"6","key":"10.1016\/j.nbd.2023.105997_bb0080","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s13760-020-01473-5","article-title":"Genetics of Parkinson\u2019s disease","volume":"120","author":"Cherian","year":"2020","journal-title":"Acta Neurol. Belg."},{"issue":"11","key":"10.1016\/j.nbd.2023.105997_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224941","article-title":"Altered expression of Notch1 in Alzheimer\u2019s disease","volume":"14","author":"Cho","year":"2019","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.nbd.2023.105997_bb0090","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201948950","article-title":"The dual role of c-src in cell-to-cell transmission of \u03b1-synuclein","volume":"21","author":"Choi","year":"2020","journal-title":"EMBO Rep."},{"issue":"15","key":"10.1016\/j.nbd.2023.105997_bb0095","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0960-9822(03)00492-5","article-title":"Learning and memory deficits in Notch mutant mice","volume":"13","author":"Costa","year":"2003","journal-title":"Curr. Biol."},{"issue":"1","key":"10.1016\/j.nbd.2023.105997_bb0100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12859-016-1007-8","article-title":"Readat: an R package for reading and working with SomaLogic ADAT files","volume":"17","author":"Cotton","year":"2016","journal-title":"BMC Bioinform."},{"issue":"16","key":"10.1016\/j.nbd.2023.105997_bb0105","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1523\/JNEUROSCI.0066-08.2008","article-title":"\u03b1-synuclein alters notch-1 expression and neurogenesis in mouse embryonic stem cells and in the hippocampus of transgenic mice","volume":"28","author":"Crews","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2023.105997_bb0110","series-title":"Neuropathological Assessment of Parkinson\u2019s Disease: Refining the Diagnostic Criteria","first-page":"1150","volume":"vol. 8","author":"Dickson","year":"2009"},{"issue":"1","key":"10.1016\/j.nbd.2023.105997_bb0115","first-page":"1","article-title":"Postnatal dysregulation of Notch signal disrupts dendrite development of adult-born neurons in the hippocampus and contributes to memory impairment","volume":"6","author":"Ding","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.nbd.2023.105997_bb0120","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/glia.22298","article-title":"Comparison of polarization properties of human adult microglia and blood-derived macrophages","volume":"60","author":"Durafourt","year":"2012","journal-title":"Glia."},{"issue":"6","key":"10.1016\/j.nbd.2023.105997_bb0125","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1074\/jbc.M010316200","article-title":"\u03b1-Synuclein is phosphorylated by members of the Src family of protein-tyrosine kinases *","volume":"276","author":"Ellis","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.nbd.2023.105997_bb0130","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-019-1670-6","article-title":"Systemic activation of NLRP3 inflammasome and plasma \u03b1-synuclein levels are correlated with motor severity and progression in Parkinson\u2019s disease","volume":"17","author":"Fan","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.nbd.2023.105997_bb0135","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/jnc.14809","article-title":"Parkinson\u2019s disease biomarkers based on \u03b1-synuclein","volume":"150","author":"Fayyad","year":"2019","journal-title":"J. Neurochem. [Internet]."},{"issue":"5","key":"10.1016\/j.nbd.2023.105997_bb0140","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the global burden of disease study 2016","volume":"18","author":"Feigin","year":"2019","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.nbd.2023.105997_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015004","article-title":"Aptamer-based multiplexed proteomic technology for biomarker discovery. Gelain F, editor","volume":"5","author":"Gold","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.nbd.2023.105997_bb0150","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/bph.12312","article-title":"Targeting midkine and pleiotrophin signalling pathways in addiction and neurodegenerative disorders: recent progress and perspectives","volume":"171","author":"Herrad\u00f5n","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2023.105997_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.00080","article-title":"Integrated metabolomics and proteomics analysis reveals plasma lipid metabolic disturbance in patients with Parkinson\u2019s disease","volume":"13","author":"Hu","year":"2020","journal-title":"Front. Mol. Neurosci."},{"issue":"3","key":"10.1016\/j.nbd.2023.105997_bb0160","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"9","key":"10.1016\/j.nbd.2023.105997_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005503","article-title":"The Parkinson\u2019s disease-associated protein kinase LRRK2 modulates notch signaling through the endosomal pathway","volume":"11","author":"Imai","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.nbd.2023.105997_bib407","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.freeradbiomed.2018.09.002","article-title":"Circadian control of BDNF-mediated Nrf2 activation in astrocytes protects dopaminergic neurons from ferroptosis","volume":"133","author":"Ishii","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.nbd.2023.105997_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms8360","article-title":"Bruton\u2019s tyrosine kinase is essential for NLRP3 inflammasome activation and contributes to ischaemic brain injury","volume":"6","author":"Ito","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2023.105997_bb0175","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbi.2012.12.008","article-title":"The inflammasome: pathways linking psychological stress, depression, and systemic illnesses","volume":"31","author":"Iwata","year":"2013","journal-title":"Brain Behav. Immun."},{"issue":"41","key":"10.1016\/j.nbd.2023.105997_bib409","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017478","article-title":"Differential proteomic analysis of serum exosomes reveals alterations in progression of Parkinson disease","volume":"98","author":"Jiang","year":"2019","journal-title":"Medicine"},{"issue":"11","key":"10.1016\/j.nbd.2023.105997_bib410","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1002\/mds.28591","article-title":"Validation of \u03b1-Synuclein in L1CAM-Immunocaptured exosomes as a biomarker for the stratification of parkinsonian syndromes","volume":"36","author":"Jiang","year":"2021","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.nbd.2023.105997_bb0180","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1096\/fj.03-0927fje","article-title":"Pleiotrophin mRNA is highly expressed in neural stem (progenitor) cells of mouse ventral mesencephalon and the product promotes production of dopaminergic neurons from embryonic stem cell-derived nestin-positive cells","volume":"18","author":"Jung","year":"2004","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.nbd.2023.105997_bib402","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11481-019-09839-0","article-title":"Inhibition of bruton\u2019s tyrosine kinase modulates microglial phagocytosis: therapeutic implications for alzheimer\u2019s disease","volume":"14","author":"Keaney","year":"2019","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"4","key":"10.1016\/j.nbd.2023.105997_bb0185","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1017\/S1461145709009924","article-title":"A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder","volume":"12","author":"Khairova","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.nbd.2023.105997_bb0190","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jamaneurol.2020.5257","article-title":"Identification of candidate Parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets","volume":"78","author":"Kia","year":"2021","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.nbd.2023.105997_bb0195","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bbadis.2009.12.009","article-title":"Pathological roles of MAPK signaling pathways in human diseases","volume":"1802","author":"Kim","year":"2010","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"10","key":"10.1016\/j.nbd.2023.105997_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026332","article-title":"From somamer-based biomarker discovery to diagnostic and clinical applications: a SOMAmer-based, streamlined multiplex proteomic assay. Hoheisel JD, editor","volume":"6","author":"Kraemer","year":"2011","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.nbd.2023.105997_bb0205","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"issue":"9","key":"10.1016\/j.nbd.2023.105997_bb0210","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1212\/WNL.0000000000003663","article-title":"Metabolomic biomarkers as strong correlates of Parkinson disease progression","volume":"88","author":"Lewitt","year":"2017","journal-title":"Neurology."},{"issue":"2","key":"10.1016\/j.nbd.2023.105997_bb0215","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1242\/dev.129.2.373","article-title":"Notch1 is required for neuronal and glial differentiation in the cerebellum","volume":"129","author":"L\u00fctolf","year":"2002","journal-title":"Development."},{"issue":"112","key":"10.1016\/j.nbd.2023.105997_bb0220","article-title":"The effect of Xinkeshu tablets on depression and anxiety symptoms in patients with coronary artery disease: results from a double-blind, randomized, placebo-controlled study","author":"Ma","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.nbd.2023.105997_bib403","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.parkreldis.2019.05.035","article-title":"TRNA-derived fragments as sex-dependent circulating candidate biomarkers for Parkinson\u2019s disease","volume":"65","author":"Magee","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.nbd.2023.105997_bb0225","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13024-016-0072-9","article-title":"Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson\u2019s disease","volume":"11","author":"Majbour","year":"2016","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.nbd.2023.105997_bb0230","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40035-020-00192-4","article-title":"CSF total and oligomeric \u03b1-Synuclein along with TNF-\u03b1 as risk biomarkers for Parkinson\u2019s disease: a study in LRRK2 mutation carriers","volume":"9","author":"Majbour","year":"2020","journal-title":"Transl. Neurodegener."},{"issue":"9","key":"10.1016\/j.nbd.2023.105997_bb0235","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/mds.28611","article-title":"Cerebrospinal \u03b1-synuclein oligomers reflect disease motor severity in DeNoPa longitudinal cohort","volume":"36","author":"Majbour","year":"2021","journal-title":"Move. Dis. [Internet]."},{"issue":"14","key":"10.1016\/j.nbd.2023.105997_bb0240","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1212\/WNL.0b013e3182a6cbd5","article-title":"Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort","volume":"81","author":"Mollenhauer","year":"2013","journal-title":"Neurology."},{"issue":"2","key":"10.1016\/j.nbd.2023.105997_bb0245","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1212\/WNL.0000000000002651","article-title":"Monitoring of 30 marker candidates in early Parkinson disease as progression markers","volume":"87","author":"Mollenhauer","year":"2016","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2023.105997_bb0250","article-title":"Validation of serum neurofilament light chain as a biomarker of Parkinson\u2019s disease progression","volume":"762237","author":"Mollenhauer","year":"2019","journal-title":"bioRxiv."},{"issue":"1","key":"10.1016\/j.nbd.2023.105997_bb0255","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/mds.27492","article-title":"Baseline predictors for progression 4 years after Parkinson\u2019s disease diagnosis in the De Novo Parkinson cohort (DeNoPa)","volume":"34","author":"Mollenhauer","year":"2019","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.nbd.2023.105997_bb0260","article-title":"Midkine as a factor to counteract the deposition of amyloid \u03b2-peptide plaques: in vitro analysis and examination in knockout mice","volume":"4","author":"Muramatsul","year":"2011","journal-title":"Int. Arch. Med."},{"key":"10.1016\/j.nbd.2023.105997_bib408","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.matbio.2013.09.003","article-title":"Lumican affects tumor cell functions, tumor-ECM interactions, angiogenesis and inflammatory response","volume":"35","author":"Nikitovic","year":"2014","journal-title":"Matrix Biol."},{"issue":"8","key":"10.1016\/j.nbd.2023.105997_bb0265","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41380-018-0347-3","article-title":"Negr1 controls adult hippocampal neurogenesis and affective behaviors","volume":"24","author":"Noh","year":"2019","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.nbd.2023.105997_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051170","article-title":"Dual-specificity phosphatases in neuroblastoma cell growth and differentiation","volume":"20","author":"Nunes-Xavier","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.nbd.2023.105997_bb0275","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.pnpbp.2009.02.005","article-title":"Dopaminergic hypofunctions and prepulse inhibition deficits in mice lacking midkine","volume":"33","author":"Ohgake","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.nbd.2023.105997_bb0280","first-page":"1","article-title":"Alpha-synuclein research: defining strategic moves in the battle against Parkinson\u2019s disease","volume":"7","author":"Oliveira","year":"2021","journal-title":"npj Parkinson\u2019s Dis. [Internet]"},{"issue":"2","key":"10.1016\/j.nbd.2023.105997_bb0285","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/mds.27897","article-title":"CSF or serum neurofilament light added to \u03b1-synuclein panel discriminates Parkinson\u2019s from controls","volume":"35","author":"Oosterveld","year":"2020","journal-title":"Move. Dis. [Internet]."},{"issue":"1","key":"10.1016\/j.nbd.2023.105997_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-018-0779-z","article-title":"Role of Bruton\u2019s tyrosine kinase in B cells and malignancies","volume":"17","author":"Pal Singh","year":"2018","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.nbd.2023.105997_bb0295","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1084\/jem.20182191","article-title":"Fyn kinase regulates misfolded \u03b1-synuclein uptake and NLRP3 inflammasome activation in microglia","volume":"216","author":"Panicker","year":"2019","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.nbd.2023.105997_bb0300","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/mds.25772","article-title":"Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson\u2019s disease","volume":"29","author":"Parnetti","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2023.105997_bb0305","series-title":"CSF and Blood Biomarkers for Parkinson\u2019s Disease","first-page":"573","volume":"vol. 18","author":"Parnetti","year":"2019"},{"key":"10.1016\/j.nbd.2023.105997_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"6\u20138","key":"10.1016\/j.nbd.2023.105997_bb0315","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.mod.2012.11.002","article-title":"The role of cell adhesion molecules for navigating axons: density matters","volume":"130","author":"Pollerberg","year":"2013","journal-title":"Mech. Dev."},{"issue":"10","key":"10.1016\/j.nbd.2023.105997_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002931","article-title":"Characterization of Parkinson\u2019s disease using blood-based biomarkers: a multicohort proteomic analysis","volume":"16","author":"Posavi","year":"2019","journal-title":"PLoS Med."},{"key":"10.1016\/j.nbd.2023.105997_bib401","article-title":"Src family kinases (SFKs): critical regulators of microglial homeostatic functions and neurodegeneration in Parkinson\u2019s and Alzheimer\u2019s diseases","author":"Portugal","year":"2021","journal-title":"FEBS J."},{"issue":"8","key":"10.1016\/j.nbd.2023.105997_bb0325","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00702-010-0568-3","article-title":"Mice with genetic deletion of the heparin-binding growth factor midkine exhibit early preclinical features of Parkinson\u2019s disease","volume":"118","author":"Prediger","year":"2011","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"3","key":"10.1016\/j.nbd.2023.105997_bib411","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10072-012-0996-y","article-title":"Proteomic identification of aldolase A as an autoantibody target in patients with atypical movement disorders","volume":"34","author":"Privitera","year":"2013","journal-title":"Neurol. Sci."},{"issue":"3","key":"10.1016\/j.nbd.2023.105997_bb0330","first-page":"280","article-title":"Future Directions of Cytokine Hypothesis in Depression: \u2018NLRP3 inflamazomu.\u2019","volume":"23","author":"Sahin","year":"2016"},{"issue":"1","key":"10.1016\/j.nbd.2023.105997_bb0335","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1474-4422(14)70287-X","article-title":"Prediagnostic presentations of Parkinson\u2019s disease in primary care: a case-control study","volume":"14","author":"Schrag","year":"2015","journal-title":"Lancet Neurol."},{"issue":"5440","key":"10.1016\/j.nbd.2023.105997_bb0340","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1126\/science.286.5440.741","article-title":"Contact-dependent inhibition of cortical neurite growth mediated by notch signaling","volume":"286","author":"\u0160estan","year":"1999","journal-title":"Science."},{"issue":"1","key":"10.1016\/j.nbd.2023.105997_bb0345","first-page":"1","article-title":"Neural cell adhesion molecule Negr1 deficiency in mouse results in structural brain endophenotypes and behavioral deviations related to psychiatric disorders","volume":"9","author":"Singh","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2023.105997_bb0350","series-title":"SOMAscanTM Proteomic Assay Technical White Paper","author":"SomaLogic","year":"2015"},{"issue":"2","key":"10.1016\/j.nbd.2023.105997_bb0355","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/dvdy.22525","article-title":"Non-canonical notch function in motor axon guidance is mediated by Rac GTPase and the GEF1 domain of trio","volume":"240","author":"Song","year":"2011","journal-title":"Dev. Dyn."},{"issue":"11","key":"10.1016\/j.nbd.2023.105997_bb0360","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.neurobiolaging.2007.04.006","article-title":"Synuclein activates microglia in a model of Parkinson\u2019s disease","volume":"29","author":"Su","year":"2008","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.nbd.2023.105997_bb0365","first-page":"117","article-title":"Association between serum alpha-synuclein levels and Parkinson\u2019s disease stage","volume":"10","author":"Syafrita","year":"2022","journal-title":"Global. Med. Health Commun. [Internet]."},{"issue":"17","key":"10.1016\/j.nbd.2023.105997_bib405","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1523\/JNEUROSCI.2952-16.2017","article-title":"Deficiency in neuronal TGF-\u03b2 signaling leads to nigrostriatal degeneration and activation of TGF-\u03b2 signaling protects against MPTP neurotoxicity in mice","volume":"37","author":"Tesseur","year":"2017","journal-title":"J. Neurosci."},{"issue":"15","key":"10.1016\/j.nbd.2023.105997_bb0370","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.nbd.2023.105997_bib406","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073629","article-title":"CD33 rs2455069 SNP: correlation with alzheimer\u2019s disease and hypothesis of functional role","volume":"23","author":"Tortora","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2023.105997_bb0375","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fcell.2021.630479","article-title":"Targeting the NLRP3 Inflammasome via BTK","volume":"9","author":"Weber","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"7","key":"10.1016\/j.nbd.2023.105997_bb0380","doi-asserted-by":"crossref","DOI":"10.1002\/mds.26563","article-title":"Serum immune markers and disease progression in an incident Parkinson\u2019s disease cohort (ICICLE-PD)","volume":"31","author":"Williams-Gray","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2023.105997_bb0385","article-title":"Identification of a novel proteomic biomarker in Parkinson\u2019s disease: discovery and replication in blood, brain and CSF","author":"Winchester","year":"2021","journal-title":"Brain Commun."},{"issue":"6","key":"10.1016\/j.nbd.2023.105997_bb0390","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/mp.2016.46","article-title":"Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition","volume":"21","author":"Wong","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2023.105997_bb0395","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fnins.2020.00045","article-title":"Src inhibition attenuates neuroinflammation and protects dopaminergic neurons in Parkinson\u2019s disease models","volume":"14","author":"Yang","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2023.105997_bb0400","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.parkreldis.2022.06.001","article-title":"Plasma and serum alpha-synuclein as a biomarker in Parkinson\u2019s disease: a meta-analysis","volume":"99","author":"Zubelzu","year":"2022","journal-title":"Parkinsonism Relat. Disord."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996123000116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996123000116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:35:30Z","timestamp":1760852130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996123000116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":91,"alternative-id":["S0969996123000116"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2023.105997","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cross-sectional proteomic expression in Parkinson's disease-related proteins in drug-na\u00efve patients vs healthy controls with longitudinal clinical follow-up","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2023.105997","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105997"}}